These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 3773882

  • 1. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP, Posner P.
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [Abstract] [Full Text] [Related]

  • 2. Effect of acetylethylcholine mustard on muscarinic receptor-coupled attenuation of cAMP formation in intact GH3 cells.
    Bolden CP, Baker SP.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):136-41. PubMed ID: 2164088
    [Abstract] [Full Text] [Related]

  • 3. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW, Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [Abstract] [Full Text] [Related]

  • 4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 5. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 6. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 7. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
    Galper JB, Dziekan LC, O'Hara DS, Smith TW.
    J Biol Chem; 1982 Sep 10; 257(17):10344-56. PubMed ID: 7107608
    [Abstract] [Full Text] [Related]

  • 8. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul 10; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 9. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J, Chuang DM.
    J Pharmacol Exp Ther; 1987 Jul 10; 242(1):238-44. PubMed ID: 3039110
    [Abstract] [Full Text] [Related]

  • 10. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ, Jenden DJ.
    Mol Pharmacol; 1985 Aug 10; 28(2):107-19. PubMed ID: 3839562
    [Abstract] [Full Text] [Related]

  • 11. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH, Goldstein D.
    J Pharmacol Exp Ther; 1986 Aug 10; 238(2):580-6. PubMed ID: 3016242
    [Abstract] [Full Text] [Related]

  • 12. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK, Meeker RB, Martin MW.
    J Pharmacol Exp Ther; 1983 Dec 10; 227(3):570-7. PubMed ID: 6317839
    [Abstract] [Full Text] [Related]

  • 13. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar 10; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul 10; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 15. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep 10; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 16. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX, Mei L, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1987 Sep 10; 242(3):981-90. PubMed ID: 3116203
    [Abstract] [Full Text] [Related]

  • 17. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W, Wolfe BB.
    Mol Pharmacol; 1989 Nov 10; 36(5):749-57. PubMed ID: 2555673
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul 10; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 19. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ, Lee JM.
    Exp Neurol; 1999 Aug 10; 158(2):451-8. PubMed ID: 10415152
    [Abstract] [Full Text] [Related]

  • 20. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T, Ehlert FJ.
    Mol Pharmacol; 1992 Apr 10; 41(4):718-26. PubMed ID: 1569923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.